Fact CheckerSign in

NCT04462601Active, not recruiting

Descriptive Study of Variations in Serum Translocation Markers of the Intestinal Microbiota in Patients With Gougerot-Sjögren Syndrome According to Disease Activity

Source: ClinicalTrials.gov · Last updated 17 Nov 2025

Brief summary (registry, in English)

Gougerot-Sjögren syndrome or Sjögren syndrome is a chronic autoimmune disease belonging to connectivitis, the classic triad of symptoms being the association of a sicca syndrome (generally predominant in the mouth and / or ocular, but also present at the cutaneous, vaginal or tracheal level), diffuse arthromyalgia and marked fatigue. The study investigators hypothesize that changes in the gut microbiota, by modulating gut permeability and thereby promoting microbial translocation, would have immunomodulatory effects that could be correlated to changes in the activity of Gougerot-Sjögren disease.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
50 (estimated)
First submitted
3 Jul 2020
Start date
13 Nov 2020
Primary completion date
Oct 2028
Lead sponsor
Centre Hospitalier Universitaire de Nīmes
NCT number
NCT04462601

What you commit to

  • Study type: Observational
  • Planned participants: 50
  • From 13 Nov 2020 to the primary completion date, Oct 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • The subject is participating in a category I interventional study, or is in a period of exclusion determined by a previous study

Other illness

  • Patients with secondary Sjögren's syndrome

Other

  • It is impossible to give the subject informed information
  • The patient is under safeguard of justice or state guardianship
  • Pregnant, parturient or breastfeeding patients

Who the study is looking for

  • The patient must be a member or beneficiary of a health insurance plan
  • Patients with primary Sjögren's syndrome according to the AECG criteria

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
CHU de Nîmes
Coordinator of this site? Confirm its status
NîmesFranceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.